Sponsor or institution
Clinical trials and research at Centre Georges Francois Leclerc
As of November 12, 2026, Find a Trial lists 11 clinical trials run by Centre Georges Francois Leclerc that are recruiting, in France. By phase: Phase 2 (2), Phase 1/2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 11Clinical trials
- 1Country
Newest trials
All recruiting trials (11)
-
Predicting who responds to anti-PD-1/PD-L1 therapy using blood extracellular vesicle tests
This study tests whether immune biomarkers found in blood extracellular vesicles can predict who with NSCLC or unresectable melanoma will respond to anti-PD-1/PD-L1 therapies.
-
Understanding Cancer Patients' Preferences for Genetic Information Before Exome Analysis
This study is trying to find out how cancer patients want to receive genetic information before they have a specific genetic test, to make sure they understand their treatment options better.
-
Ultra-rapid testing for BRCA1/2 mutations in breast cancer patients
This study tests a fast BRCA1/2 mutation screening for breast cancer patients to see if it can reduce their waiting time for results and help ease their anxiety.
-
Evaluating FOLFIRINOX treatment for advanced pancreatic cancer
This study is testing if a specific chemotherapy called FOLFIRINOX can help people with advanced pancreatic cancer feel better and live longer compared to other treatments.
-
Evaluating a new treatment for advanced lung cancer with low PD-L1 levels
This study is testing a new treatment combining mirdametinib and chemotherapy for people with advanced lung cancer and low PD-L1 levels to see if it helps them.
-
Using a non-magnetic screen to guide breathing during MRI-guided radiotherapy for mobile cancerous lesions
This study is testing if using a special non-magnetic screen during MRI-guided radiotherapy can help patients with mobile cancerous lesions breathe better and improve their treatment experience.
-
Monitoring immune responses in breast cancer patients during treatment
This study is testing how different treatments for breast cancer affect the immune system by collecting blood samples from women during their therapy.
-
Using advanced genetic analysis to guide cancer treatment decisions
This study is testing whether a more detailed genetic analysis can help doctors make better treatment choices for patients with advanced cancer compared to a simpler test.
-
Comparing two imaging techniques for detecting lesions in multiple myeloma patients
This study is testing which of two imaging techniques is better at finding lesions in newly diagnosed multiple myeloma patients.
-
Identifying genetic factors in early-onset cancer using exome analysis
This study is trying to find new genetic clues in patients with early-onset cancer who didn't get answers from previous tests to help improve how we understand and diagnose these cancers.
-
Evaluating a new radiotherapy approach for high-risk prostate cancer
This study is testing a new way of giving radiation therapy to see if it can effectively treat high-risk prostate cancer with fewer sessions and less side effects.
Quick answers
How many clinical trials run by Centre Georges Francois Leclerc are recruiting right now?
11, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
All of them have sites in France. Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 2, Phase 1/2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.